In planta episomal synthesis of cinnamaldehyde for sustainable pest control
A novel in planta episomal expression system enables the production of cinnamaldehyde, a potent natural pesticide, without genomic integration or toxicity. This method offers a sustainable and eco-friendly alternative to synthetic pesticides, addressing regulatory and ecological concerns.
Overview
In planta episomal synthesis of cinnamaldehyde offers a breakthrough in sustainable pest control. By leveraging a novel, integration-free episomal expression method, this technology enables the production of cinnamaldehyde, a plant-derived bioactive compound with strong insecticidal and nematocidal properties. Without the need for genomic alterations, this method addresses ecological and regulatory challenges associated with synthetic pesticides, providing a scalable and eco-friendly solution for pest management.
Technical specifications
The system employs a patent-pending synthetic plant episome to co-express three key biosynthetic genes: phenylalanine ammonia-lyase (PAL), 4-coumarate CoA ligase (C4H), and cinnamoyl-CoA reductase (CCR). These genes are delivered using a peptide-based DNA delivery system, ensuring stable yet non-integrative expression. The process is validated through HPLC and GC-MS metabolite profiling, digital qPCR, episome rescue assays, and sequencing. Initial trials involve Arabidopsis and Nicotiana benthamiana, with plans to extend to soybean and other crops.
Technology readiness level
The technology is currently at TRL 3, with laboratory validation underway. Future validation steps include testing in diverse crops, assessing pest suppression efficacy, and ensuring the absence of phytotoxicity or harm to beneficial organisms. The system's stability and non-integration will be rigorously monitored to ensure compliance with biosafety and regulatory standards.
About University of South Dakota
The University of South Dakota is a comprehensive public research university based in Vermillion with a statewide footprint through multiple campuses and professional programs. Industry collaboration is enabled by the USD Discovery District, a corporate–academic research park in Sioux Falls that offers flexible R&D space and adjacency to growing employers. The Sanford School of Medicine operates across regional sites and clinical departments embedded with major hospital systems, providing access to clinicians, patients and data for translational work. Research is supported by competitive federal funding and centralized sponsored-programs administration. A dedicated technology transfer office guides IP, licensing and startup formation to speed commercialization.
Inquire about this partnering listing
Looking for
Industry applications
delivered to your inbox.